Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
Is a |
Product containing colistin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Colistin (substance) |
false |
Inferred relationship |
Some |
|
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
Is a |
colistinsulfat + hydrocortisonacetat + neomycinsulfat |
false |
Inferred relationship |
Some |
|
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Some |
|
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocortisone (substance) |
false |
Inferred relationship |
Some |
|
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neomycin sulfate |
false |
Inferred relationship |
Some |
|
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antiinfektiøst middel til huden |
false |
Inferred relationship |
Some |
|
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocortisone acetate |
false |
Inferred relationship |
Some |
|
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
binyrehormonmiddel |
false |
Inferred relationship |
Some |
|
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Colistin sulfate |
false |
Inferred relationship |
Some |
|
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Baktericid |
false |
Inferred relationship |
Some |
|
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
Has manufactured dose form |
Otic dose form (dose form) |
false |
Inferred relationship |
Some |
|
|